MerTK inhibition in tumor leukocytes decreases tumor growth and metastasis. Cook RS, Jacobsen KM, Wofford AM, DeRyckere D, Stanford J, Prieto AL, Redente E, Sandahl M, Hunter DM, Strunk KE, Graham DK, Earp HS (2013) J Clin Invest 123: 3231-42 Autophagy-related protein Vps34 controls the homeostasis and function of antigen cross-presenting CD8α dendritic cells. Parekh VV, Pabbisetty SK, Wu L, Sebzda E, Martinez J, Zhang J, Van Kaer L (2017) Proc Natl Acad Sci U S A 114: E6371-E6380 Preconditioned endothelial progenitor cells reduce formation of melanoma metastases through SPARC-driven cell-cell interactions and endocytosis. Defresne F, Bouzin C, Grandjean M, Dieu M, Raes M, Hatzopoulos AK, Kupatt C, Feron O (2011) Cancer Res 71: 4748-57 Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy. Geng L, Donnelly E, McMahon G, Lin PC, Sierra-Rivera E, Oshinka H, Hallahan DE (2001) Cancer Res 61: 2413-9 Induction of melanoma in murine macrophage inflammatory protein 2 transgenic mice heterozygous for inhibitor of kinase/alternate reading frame. Yang J, Luan J, Yu Y, Li C, DePinho RA, Chin L, Richmond A (2001) Cancer Res 61: 8150-7 Opposing roles of murine duffy antigen receptor for chemokine and murine CXC chemokine receptor-2 receptors in murine melanoma tumor growth. Horton LW, Yu Y, Zaja-Milatovic S, Strieter RM, Richmond A (2007) Cancer Res 67: 9791-9 Low levels of tumor necrosis factor alpha increase tumor growth by inducing an endothelial phenotype of monocytes recruited to the tumor site. Li B, Vincent A, Cates J, Brantley-Sieders DM, Polk DB, Young PP (2009) Cancer Res 69: 338-48 Mdm2 and aurora kinase a inhibitors synergize to block melanoma growth by driving apoptosis and immune clearance of tumor cells. Vilgelm AE, Pawlikowski JS, Liu Y, Hawkins OE, Davis TA, Smith J, Weller KP, Horton LW, McClain CM, Ayers GD, Turner DC, Essaka DC, Stewart CF, Sosman JA, Kelley MC, Ecsedy JA, Johnston JN, Richmond A (2015) Cancer Res 75: 181-93 Myeloid IKKβ promotes antitumor immunity by modulating CCL11 and the innate immune response. Yang J, Hawkins OE, Barham W, Gilchuk P, Boothby M, Ayers GD, Joyce S, Karin M, Yull FE, Richmond A (2014) Cancer Res 74: 7274-84 Systemic targeting inhibitor of kappaB kinase inhibits melanoma tumor growth. Yang J, Pan WH, Clawson GA, Richmond A (2007) Cancer Res 67: 3127-34 Inhibition of p-STAT3 enhances IFN-alpha efficacy against metastatic melanoma in a murine model. Kong LY, Gelbard A, Wei J, Reina-Ortiz C, Wang Y, Yang EC, Hailemichael Y, Fokt I, Jayakumar A, Qiao W, Fuller GN, Overwijk WW, Priebe W, Heimberger AB (2010) Clin Cancer Res 16: 2550-61 Targeting aurora kinases limits tumour growth through DNA damage-mediated senescence and blockade of NF-κB impairs this drug-induced senescence. Liu Y, Hawkins OE, Su Y, Vilgelm AE, Sobolik T, Thu YM, Kantrow S, Splittgerber RC, Short S, Amiri KI, Ecsedy JA, Sosman JA, Kelley MC, Richmond A (2013) EMBO Mol Med 5: 149-66 NF-κB inducing kinase (NIK) modulates melanoma tumorigenesis by regulating expression of pro-survival factors through the β-catenin pathway. Thu YM, Su Y, Yang J, Splittgerber R, Na S, Boyd A, Mosse C, Simons C, Richmond A (2012) Oncogene 31: 2580-92 Effects of MGSA/GRO alpha on melanocyte transformation. Balentien E, Mufson BE, Shattuck RL, Derynck R, Richmond A (1991) Oncogene 6: 1115-24 IL-17RC is critically required to maintain baseline A20 production to repress JNK isoform-dependent tumor-specific proliferation. Yan C, Lei Y, Lin TJ, Hoskin DW, Ma A, Wang J (2017) Oncotarget 8: 43153-43168 Ratio of IgG:IgM antibodies to sialyl Lewis(x) and GM3 correlates with tumor growth after immunization with melanoma-cell vaccine with different adjuvants in mice. Ravindranath MH, Kelley MC, Jones RC, Amiri AA, Bauer PM, Morton DL (1998) Int J Cancer 75: 117-24 Phenotypic diversity of the lung vasculature in experimental models of metastases. Oh Y, Mohiuddin I, Sun Y, Putnam JB, Hong WK, Arap W, Pasqualini R (2005) Chest 128: 596S-600S PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells. Parekh VV, Lalani S, Kim S, Halder R, Azuma M, Yagita H, Kumar V, Wu L, Kaer LV (2009) J Immunol 182: 2816-26 Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways. Hayakawa Y, Takeda K, Yagita H, Van Kaer L, Saiki I, Okumura K (2001) J Immunol 166: 6012-8 Targeting melanoma growth and viability reveals dualistic functionality of the phosphonothionate analogue of carba cyclic phosphatidic acid. Altman MK, Gopal V, Jia W, Yu S, Hall H, Mills GB, McGinnis AC, Bartlett MG, Jiang G, Madan D, Prestwich GD, Xu Y, Davies MA, Murph MM (2010) Mol Cancer 9: 140 The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma. Haghnegahdar H, Du J, Wang D, Strieter RM, Burdick MD, Nanney LB, Cardwell N, Luan J, Shattuck-Brandt R, Richmond A (2000) J Leukoc Biol 67: 53-62 Host deficiency in Vav2/3 guanine nucleotide exchange factors impairs tumor growth, survival, and angiogenesis in vivo. Brantley-Sieders DM, Zhuang G, Vaught D, Freeman T, Hwang Y, Hicks D, Chen J (2009) Mol Cancer Res 7: 615-23 Agonistic antibody to CD40 boosts the antitumor activity of adoptively transferred T cells in vivo. Liu C, Lewis CM, Lou Y, Xu C, Peng W, Yang Y, Gelbard AH, Lizée G, Zhou D, Overwijk WW, Hwu P (2012) J Immunother 35: 276-82 Distant regulatory elements in a Sox10-beta GEO BAC transgene are required for expression of Sox10 in the enteric nervous system and other neural crest-derived tissues. Deal KK, Cantrell VA, Chandler RL, Saunders TL, Mortlock DP, Southard-Smith EM (2006) Dev Dyn 235: 1413-32 The Foxc2 transcription factor regulates tumor angiogenesis. Sano H, Leboeuf JP, Novitskiy SV, Seo S, Zaja-Milatovic S, Dikov MM, Kume T (2010) Biochem Biophys Res Commun 392: 201-6
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.